Straits Research Pvt Ltd
The Global Skin Lightening Products Market size is predicted to reach at USD 16.08 billion by 2030, increasing at a CAGR of 5.56% - Straits Research
January 10, 2024 08:30 ET | Straits Research
New York, United States, Jan. 10, 2024 (GLOBE NEWSWIRE) -- These skin-lightening procedures lighten the complexion. Getting skin-whitening creams is easy. Skin whitening treatments like lotions,...
Asia-Pacific Scar Management Market
Asia-Pacific Scar Management Analysis Report 2023: Market is Expected to Reach $363.4 Million by 2030 - Opportunities in the Emergence of Remote Monitoring and Digital Health Solutions
January 08, 2024 12:33 ET | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Scar Management Market - Analysis and Forecast, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference   
January 08, 2024 08:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
journeylogo (1).jpg
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
January 05, 2024 08:30 ET | Journey Medical Corporation
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea NDA submission supported by positive Phase...
STRATA Skin Sciences Logo.jpg
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
January 03, 2024 08:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
22157.jpg
Global Carboxy Therapy Market Forecast Report to 2028 - Compound Annual Growth of 12.25% Forecast During 2023-2028
December 22, 2023 04:33 ET | Research and Markets
Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Carboxy Therapy Market: Analysis and Trends by Type, Application, End User and Region and Forecast up to 2028" report has been added to ...
PhysicianLogo.jpg
Physician Growth Partners advises Advanced Dermatology in partnership with Forefront Dermatology
December 20, 2023 09:21 ET | Physician Growth Partners
CHICAGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Physician Growth Partners (“PGP”) is pleased to have advised Advanced Dermatology (“Advanced Derm”), a sixteen-provider medical and cosmetic dermatology...
AIVAVA BIOPHARMA COLOR.png
AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer
December 11, 2023 08:00 ET | AiViva Biopharma
Novel Non-surgical Intradermal Treatment for Basel Cell Carcinoma COSA MESA, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced...
BMS Attributes Sotyk
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
December 07, 2023 12:01 ET | Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
journeylogo (1).jpg
Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
December 06, 2023 08:00 ET | Journey Medical Corporation
SCOTTSDALE, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses...